National Institute for Health and Care Excellence7 日
People with a rare form of blood cancer are set to benefit after NICE recommends new ...
Hundreds of people with a rare form of blood cancer could be set to benefit after NICE recommended a new targeted treatment ...
National Institute for Health and Care Excellence5 日
Introducing CHEERS-AI: improving health economic evaluation reporting for AI technologies
CHEERS-AI builds on existing best practice in health economic evaluation reporting by including the original 28 standards ...
National Institute for Health and Care Excellence13 日
Heart failure patients to be remotely monitored by technology shown to cut hospitalisations ...
Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...
National Institute for Health and Care Excellence5 日
More people are benefitting from NICE-recommended statins to reduce heart attacks and strokes
Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their ...
National Institute for Health and Care Excellence13 日
New Alzheimer’s treatment donanemab does not currently demonstrate value for the NHS says ...
Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...